University Of Michigan Ann Arbor

Youths with type 1 or type 2 diabetes are at a higher risk of being diagnosed with diabetic retinopathy later in life and should undergo early ophthalmic examinations.

Many neonatal intensive care units have difficulty enlisting ophthalmologists to screen for retinopathy of prematurity, but most are not yet convinced telemedicine can help fill the void, according to a study.

Psychiatric illness, corticosteroid use, narcotic use, low hemoglobin levels and a high number of IBD-related hospitalizations were predictive of high health care use and costs in the following year for patients with inflammatory bowel disease, according to recent study data.

Adults with follicular or medullary thyroid cancer have a higher risk for bone metastases or skeletal-related events compared with adults with papillary thyroid cancer, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

Premenopausal women with higher endogenous estradiol levels have a lower risk for developing type 2 diabetes in midlife as they transition through menopause vs. women with lower endogenous estradiol levels, according to an analysis of data from the SWAN study.

Women transitioning through menopause may have a higher risk for diabetes if they had lower premenopausal estradiol levels and a slower rate of follicle-stimulating hormone change during the early transition, according to recent data.

WASHINGTON — At the American College of Rheumatology Annual Meeting, Dinesh Khanna, MD, rheumatologist and director of the scleroderma program at the University of Michigan, reviewed open-label extension data from the fasscinate trial. The trial was a phase 2 randomized controlled study of subcutaneous tocilizumab for patients with early systemic sclerosis (SSc) that was extended an additional 48 weeks from the initial 48-week period.

LAS VEGAS — Tenapanor at a dose of 50 mg twice per day significantly improved global endpoints in constipation-predominant irritable bowel syndrome, according to phase 2b trial data presented at ACG 2016.

About half of patients with diarrhea-predominant irritable bowel syndrome had adequate symptom relief on either a low FODMAP diet or traditional IBS dietary advice, according to results from a randomized controlled trial.

LAS VEGAS — In this exclusive video from ACG 2016, William D. Chey, MD, professor of medicine, director of the GI Physiology Lab, and co-director of the Michigan Bowel Control Program at the University of Michigan, Ann Arbor, discusses the results of a phase 2b randomized controlled trial of tenapanor (Ardelyx), a small molecule that inhibits sodium reabsorption via the NHE3 receptor, in patients with constipation predominant irritable bowel syndrome.